MARCHESE, PAOLA VALERIA
MARCHESE, PAOLA VALERIA
DIPARTIMENTO DI SCIENZE MEDICHE E CHIRURGICHE
Dottorandi
Development and validation of a new tool to estimate early mortality in patients with advanced cancer treated with immunotherapy
2024 De Giglio, Andrea; Leonetti, Alessandro; Comito, Francesca; Filippini, Daria Maria; Mollica, Veronica; Rihawi, Karim; Peroni, Marianna; Mazzaschi, Giulia; Ricciotti, Ilaria; Carosi, Francesca; Marchetti, Andrea; Rosellini, Matteo; Gagliano, Ambrogio; Favorito, Valentina; Nobili, Elisabetta; Gelsomino, Francesco; Melotti, Barbara; Marchese, Paola Valeria; Sperandi, Francesca; Di Federico, Alessandro; Buti, Sebastiano; Perrone, Fabiana; Massari, Francesco; Pantaleo, Maria Abbondanza; Tiseo, Marcello; Ardizzoni, Andrea
Agnostic Approvals in Oncology: Getting the Right Drug to the Right Patient with the Right Genomics
2023 Valentina Tateo; Paola Valeria Marchese; Veronica Mollica; Francesco Massari; Razelle Kurzrock; Jacob J. Adashek
Clinical Utility and Application of Liquid Biopsy Genotyping in Lung Cancer: A Comprehensive Review
2023 Nigro M.C.; Marchese P.V.; Deiana C.; Casadio C.; Galvani L.; Di Federico A.; De Giglio A.
TERT promoter mutations and the outcome of patients with advanced urothelial carcinoma treated by platinum-based chemotherapy or pembrolizumab
2023 Mollica, Veronica; Tassinari, Elisa; Santoni, Matteo; Marchese, Paola Valeria; Giunchi, Francesca; Maloberti, Thais; Tateo, Valentina; Ricci, Costantino; Rosellini, Matteo; Marchetti, Andrea; Fiorentino, Michelangelo; Biase, Dario De; Massari, Francesco
A hypothesis-generating analysis on the role of TERT promoter mutation in advanced urothelial carcinoma treated with immunotherapy
2022 Marchese, Paola Valeria; Mollica, Veronica; De Biase, Dario; Giunchi, Francesca; Tassinari, Elisa; Marchetti, Andrea; Rosellini, Matteo; Nuvola, Giacomo; Maloberti, Thais; Fiorentino, Michelangelo; Massari, Francesco
Implications of TERT promoter mutations and telomerase activity in solid tumors with a focus on genitourinary cancers
2022 Marchese P.V.; Mollica V.; Tassinari E.; De Biase D.; Giunchi F.; Marchetti A.; Rosellini M.; Fiorentino M.; Massari F.
Large Cell Neuroendocrine Carcinoma of the Lung: Current Understanding and Challenges
2022 Andrini E.; Marchese P.V.; De Biase D.; Mosconi C.; Siepe G.; Panzuto F.; Ardizzoni A.; Campana D.; Lamberti G.
Lymph node ratio predicts efficacy of postoperative radiation therapy in nonmetastatic Merkel cell carcinoma: A population-based analysis
2022 Lamberti G.; Andrini E.; Siepe G.; Mosconi C.; Ambrosini V.; Ricci C.; Marchese P.V.; Ricco G.; Casadei R.; Campana D.
Monitoring tumor growth rate to predict immune checkpoint inhibitors' treatment outcome in advanced NSCLC
2022 Dall'Olio, Filippo G; Parisi, Claudia; Marcolin, Laura; Brocchi, Stefano; Caramella, Caroline; Conci, Nicole; Carpani, Giulia; Gelsomino, Francesco; Ardizzoni, Stefano; Marchese, Paola Valeria; Paccapelo, Alexandro; Grilli, Giada; Golfieri, Rita; Besse, Benjamin; Ardizzoni, Andrea
Baseline total metabolic tumour volume on 2-deoxy-2-[18F]fluoro-d-glucose positron emission tomography-computed tomography as a promising biomarker in patients with advanced non-small cell lung cancer treated with first-line pembrolizumab.
2021 Dall'Olio FG, Calabrò D, Conci N, Argalia G, Marchese PV, Fabbri F, Fragomeno B, Ricci D, Fanti S, Ambrosini V, Ardizzoni A.
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| Development and validation of a new tool to estimate early mortality in patients with advanced cancer treated with immunotherapy | De Giglio, Andrea; Leonetti, Alessandro; Comito, Francesca; Filippini, Daria Maria; Mollica, Vero...nica; Rihawi, Karim; Peroni, Marianna; Mazzaschi, Giulia; Ricciotti, Ilaria; Carosi, Francesca; Marchetti, Andrea; Rosellini, Matteo; Gagliano, Ambrogio; Favorito, Valentina; Nobili, Elisabetta; Gelsomino, Francesco; Melotti, Barbara; Marchese, Paola Valeria; Sperandi, Francesca; Di Federico, Alessandro; Buti, Sebastiano; Perrone, Fabiana; Massari, Francesco; Pantaleo, Maria Abbondanza; Tiseo, Marcello; Ardizzoni, Andrea | 2024-01-01 | CANCER IMMUNOLOGY, IMMUNOTHERAPY | - | 1.01 Articolo in rivista | Cancer Immunol Immunot 2024 [Early Mortality DeGiglio].pdf; 262_2024_3836_MOESM1_ESM.docx |
| Agnostic Approvals in Oncology: Getting the Right Drug to the Right Patient with the Right Genomics | Valentina Tateo; Paola Valeria Marchese; Veronica Mollica; Francesco Massari; Razelle Kurzrock; J...acob J. Adashek | 2023-01-01 | PHARMACEUTICALS | - | 1.01 Articolo in rivista | Pharmaceuticals 2023 [Agnostic].pdf |
| Clinical Utility and Application of Liquid Biopsy Genotyping in Lung Cancer: A Comprehensive Review | Nigro M.C.; Marchese P.V.; Deiana C.; Casadio C.; Galvani L.; Di Federico A.; De Giglio A. | 2023-01-01 | LUNG CANCER: TARGETS AND THERAPY | - | 1.01 Articolo in rivista | - |
| TERT promoter mutations and the outcome of patients with advanced urothelial carcinoma treated by platinum-based chemotherapy or pembrolizumab | Mollica, Veronica; Tassinari, Elisa; Santoni, Matteo; Marchese, Paola Valeria; Giunchi, Francesca...; Maloberti, Thais; Tateo, Valentina; Ricci, Costantino; Rosellini, Matteo; Marchetti, Andrea; Fiorentino, Michelangelo; Biase, Dario De; Massari, Francesco | 2023-01-01 | PATHOLOGY RESEARCH AND PRACTICE | - | 1.01 Articolo in rivista | - |
| A hypothesis-generating analysis on the role of TERT promoter mutation in advanced urothelial carcinoma treated with immunotherapy | Marchese, Paola Valeria; Mollica, Veronica; De Biase, Dario; Giunchi, Francesca; Tassinari, Elisa...; Marchetti, Andrea; Rosellini, Matteo; Nuvola, Giacomo; Maloberti, Thais; Fiorentino, Michelangelo; Massari, Francesco | 2022-01-01 | PATHOLOGY RESEARCH AND PRACTICE | - | 1.01 Articolo in rivista | - |
| Implications of TERT promoter mutations and telomerase activity in solid tumors with a focus on genitourinary cancers | Marchese P.V.; Mollica V.; Tassinari E.; De Biase D.; Giunchi F.; Marchetti A.; Rosellini M.; Fio...rentino M.; Massari F. | 2022-01-01 | EXPERT REVIEW OF MOLECULAR DIAGNOSTICS | - | 1.01 Articolo in rivista | - |
| Large Cell Neuroendocrine Carcinoma of the Lung: Current Understanding and Challenges | Andrini E.; Marchese P.V.; De Biase D.; Mosconi C.; Siepe G.; Panzuto F.; Ardizzoni A.; Campana D....; Lamberti G. | 2022-01-01 | JOURNAL OF CLINICAL MEDICINE | - | 1.01 Articolo in rivista | jcm-11-01461.pdf |
| Lymph node ratio predicts efficacy of postoperative radiation therapy in nonmetastatic Merkel cell carcinoma: A population-based analysis | Lamberti G.; Andrini E.; Siepe G.; Mosconi C.; Ambrosini V.; Ricci C.; Marchese P.V.; Ricco G.; C...asadei R.; Campana D. | 2022-01-01 | CANCER MEDICINE | - | 1.01 Articolo in rivista | Lamberti_Cancer Medicine_2022.pdf; Downloads.zip |
| Monitoring tumor growth rate to predict immune checkpoint inhibitors' treatment outcome in advanced NSCLC | Dall'Olio, Filippo G; Parisi, Claudia; Marcolin, Laura; Brocchi, Stefano; Caramella, Caroline; Co...nci, Nicole; Carpani, Giulia; Gelsomino, Francesco; Ardizzoni, Stefano; Marchese, Paola Valeria; Paccapelo, Alexandro; Grilli, Giada; Golfieri, Rita; Besse, Benjamin; Ardizzoni, Andrea | 2022-01-01 | THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY | - | 1.01 Articolo in rivista | 12. Dall'Olio_Monitoring Tumor Growth Rate to predict Immune Checkpoint Inhibitors’ treatment outcome in advanced NSCLC.pdf |
| Baseline total metabolic tumour volume on 2-deoxy-2-[18F]fluoro-d-glucose positron emission tomography-computed tomography as a promising biomarker in patients with advanced non-small cell lung cancer treated with first-line pembrolizumab. | Dall'Olio FG, Calabrò D, Conci N, Argalia G, Marchese PV, Fabbri F, Fragomeno B, Ricci D, Fanti S..., Ambrosini V, Ardizzoni A. | 2021-01-01 | EUROPEAN JOURNAL OF CANCER | - | 1.01 Articolo in rivista | - |